Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Wei Jiang, Tao Li, Jingjing Wang, Ruonan Jiao, Xiao Shi, Xiaodan Huang & Guozhong Ji. (2019) miR-140-3p Suppresses Cell Growth And Induces Apoptosis In Colorectal Cancer By Targeting PD-L1. OncoTargets and Therapy 12, pages 10275-10285.
Read now
Read now
Shufang Liu, Lingling Chen & Yunfei Xu. (2018) Significance of PYK2 level as a prognosis predictor in patients with colon adenocarcinoma after surgical resection. OncoTargets and Therapy 11, pages 7625-7634.
Read now
Read now
Adrian Bartoş, Dana Bartoş, Bianca Szabo, Caius Breazu, Iulian Opincariu, Aurel Mironiuc & Cornel Iancu. (2016) Recent achievements in colorectal cancer diagnostic and therapy by the use of nanoparticles. Drug Metabolism Reviews 48:1, pages 27-46.
Read now
Read now
Chia-Che Tsai, Chih-Hsien Chang, Liang-Cheng Chen, Ya-Jen Chang, Keng-Li Lan, Yu-Hsien Wu, Chin-Wei Hsu, I-Hsiang Liu, Chung-Li Ho, Wan-Chi Lee, Hsiao-Chiang Ni, Tsui-Jung Chang, Gann Ting & Te-Wei Lee. (2011) Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice. International Journal of Nanomedicine 6, pages 2607-2619.
Read now
Read now
Articles from other publishers (37)
Jian-Fang Chen, Xi Luo, Li-Sha Xiang, Hong-Tao Li, Lin Zha, Ni Li, Jian-Ming He, Gan-Feng Xie, Xiong Xie & Hou-Jie Liang. (2016) EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling. Oncotarget 7:27, pages 41540-41558.
Crossref
Crossref
Xiao-chen Li, Shuai Wang, Xin-xin Yang, Tian-jiao Li, Jia-xing Gu, Lin Zhao, Yong-rui Bao & Xian-sheng Meng. (2023) Patrinia villosa treat colorectal cancer by activating PI3K/Akt signaling pathway. Journal of Ethnopharmacology 309, pages 116264.
Crossref
Crossref
Dingka Song, Xiuli Wang, Yongjing Ma, Ning-Ning Liu & Hui Wang. (2023) Beneficial insights into postbiotics against colorectal cancer. Frontiers in Nutrition 10.
Crossref
Crossref
Wamidh H. Talib, Ahmad Riyad Alsayed, Alaa Abuawad, Safa Daoud & Asma Ismail Mahmod. (2021) Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities. Molecules 26:9, pages 2506.
Crossref
Crossref
Chih-Hsien Chang, Ming-Cheng Chang, Ya-Jen Chang, Liang-Cheng Chen, Te-Wei Lee & Gann Ting. (2021) Translating Research for the Radiotheranostics of Nanotargeted 188Re-Liposome. International Journal of Molecular Sciences 22:8, pages 3868.
Crossref
Crossref
Shan Xu, Ali Sak & Yasin Bahadir Erol. (2021) Network Meta-analysis of First-Line Systemic Treatment for Patients With Metastatic Colorectal Cancer. Cancer Control 28, pages 107327482110334.
Crossref
Crossref
Meng-Yao Ji, Lei Yuan, Shi-Min Lu, Meng-Ting Gao, Zhi Zeng, Na Zhan, Yi-Juan Ding, Zheng-Ru Liu, Ping-Xiao Huang, Cheng Lu & Wei-Guo Dong. (2020) Glandular orientation and shape determined by computational pathology could identify aggressive tumor for early colon carcinoma: a triple-center study. Journal of Translational Medicine 18:1.
Crossref
Crossref
Chunyan Zeng, Dandan Xiong, Fei Cheng, Qingtian Luo, Qiang Wang, Jun Huang, Guilian Lan, Huan Zhong & Youxiang Chen. (2020) Retrospective analysis of LNM risk factors and the effect of chemotherapy in early colorectal cancer: A Chinese multicenter study. BMC Cancer 20:1.
Crossref
Crossref
Emilio Gil‐Martín, Javier Egea, Russel J. Reiter & Alejandro Romero. (2019) The emergence of melatonin in oncology: Focus on colorectal cancer. Medicinal Research Reviews 39:6, pages 2239-2285.
Crossref
Crossref
Hsiang‐Lin Tsai, Zhi‐Feng Miao, Yi‐Ting Chen, Ching‐Wen Huang, Yung‐Sung Yeh, I‐Ping Yang & Jaw‐Yuan Wang. (2019)
miR‐148a
inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF‐1α under non‐hypoxia/hypoxia conditions
. Journal of Cellular and Molecular Medicine 23:5, pages 3572-3582.
Crossref
Crossref
Imke Atreya, Markus Kindermann & Stefan Wirtz. (2019) Innate lymphoid cells in intestinal cancer development. Seminars in Immunology 41, pages 101267.
Crossref
Crossref
Kosuke Hiramatsu, Satoshi Serada, Takayuki Enomoto, Yusuke Takahashi, Satoshi Nakagawa, Satoshi Nojima, Akiko Morimoto, Shinya Matsuzaki, Takuhei Yokoyama, Tsuyoshi Takahashi, Minoru Fujimoto, Hiroshi Takemori, Yutaka Ueda, Kiyoshi Yoshino, Eiichi Morii, Tadashi Kimura & Tetsuji Naka. (2018) LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake. Cancer Research 78:2, pages 516-527.
Crossref
Crossref
María Fernanda Rubio, María Cecilia Lira, Francisco Damián Rosa, Adrían Dario Sambresqui, María Cecilia Salazar Güemes & Mónica Alejandra Costas. (2017) RAC3 influences the chemoresistance of colon cancer cells through autophagy and apoptosis inhibition. Cancer Cell International 17:1.
Crossref
Crossref
Weihua Li, Tian Qiu, Lei Guo & Jianming Ying. (2017) Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing. Cancer Letters 410, pages 92-99.
Crossref
Crossref
Ana Casadó, Margarita Mora, Maria Lluïsa Sagristá, Santi Rello-Varona, Pilar Acedo, Juan Carlos Stockert, Magdalena Cañete & Angeles Villanueva. (2017) Improved selectivity and cytotoxic effects of irinotecan via liposomal delivery: A comparative study on Hs68 and HeLa cells. European Journal of Pharmaceutical Sciences 109, pages 65-77.
Crossref
Crossref
Li Pan, Yuming Zhang, Wanlu Zhao, Xia Zhou, Chunxia Wang & Fan Deng. (2017) The cardiac glycoside oleandrin induces apoptosis in human colon cancer cells via the mitochondrial pathway. Cancer Chemotherapy and Pharmacology 80:1, pages 91-100.
Crossref
Crossref
Yoon Kyung Jo, Seon Ae Roh, Heejin Lee, Na Yeon Park, Eun Sun Choi, Ju-Hee Oh, So Jung Park, Ji Hyun Shin, Young-Ah Suh, Eun Kyung Lee, Dong-Hyung Cho & Jin Cheon Kim. (2017) Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells. Cancer Letters 385, pages 21-27.
Crossref
Crossref
Haiyan Zhai, Andrew Fesler, Yufeng Ba, Song Wu & Jingfang Ju. (2015) Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy. Oncotarget 6:23, pages 19735-19746.
Crossref
Crossref
Wen-song Cai, Fei Shen, Zhe Feng, Ji-wei Chen, Qi-cai Liu, Er-mao Li, Bo Xu & Jie Cao. (2015) Downregulation of CDK-8 inhibits colon cancer hepatic metastasis by regulating Wnt/β-catenin pathway. Biomedicine & Pharmacotherapy 74, pages 153-157.
Crossref
Crossref
Ming Luo, Shawn G. Clouthier, Yadwinder Deol, Suling Liu, Sunitha Nagrath, Ebrahim Azizi & Max S. Wicha. 2015. Mammary Stem Cells. Mammary Stem Cells
1
49
.
Herbert Thomas Maier, Felix Aigner, Birgit Trenkwalder, Matthias Zitt, Natalie Vallant, Alexander Perathoner, Christian Margreiter, Patrizia Moser, Johann Pratschke & Albert Amberger. (2014) Up-regulation of Neutrophil Gelatinase-Associated Lipocalin in Colorectal Cancer Predicts Poor Patient Survival. World Journal of Surgery 38:8, pages 2160-2167.
Crossref
Crossref
Bojidar M. Kojouharov, Craig M. Brackett, Jean M. Veith, Christopher P. Johnson, Ilya I. Gitlin, Ilia A. Toshkov, Anatoli S. Gleiberman, Andrei V. Gudkov & Lyudmila G. Burdelya. (2014) Toll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouracil by reducing its toxicity to normal tissues in mice. Oncotarget 5:3, pages 802-814.
Crossref
Crossref
H Zhai, B Song, X Xu, W Zhu & J Ju. (2012) Inhibition of autophagy and tumor growth in colon cancer by miR-502. Oncogene 32:12, pages 1570-1579.
Crossref
Crossref
Chin-Wei HsuYa-Jen ChangChih-Hsien ChangLiang-Cheng ChenKeng-Li LanGann TingTe-Wei Lee. (2012) Comparative Therapeutic Efficacy of Rhenium-188 Radiolabeled-Liposome and 5-Fluorouracil in LS-174T Human Colon Carcinoma Solid Tumor Xenografts. Cancer Biotherapy and Radiopharmaceuticals 27:8, pages 481-489.
Crossref
Crossref
Ki Young Choi, Eun Jung Jeon, Hong Yeol Yoon, Beom Suk Lee, Jin Hee Na, Kyung Hyun Min, Sang Yoon Kim, Seung-Jae Myung, Seulki Lee, Xiaoyuan Chen, Ick Chan Kwon, Kuiwon Choi, Seo Young Jeong, Kwangmeyung Kim & Jae Hyung Park. (2012) Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer. Biomaterials 33:26, pages 6186-6193.
Crossref
Crossref
Josefa León, Jorge Casado, Ángel Carazo, Laura Sanjuán, Ana Maté, Paloma Muñoz de Rueda, Paloma de la Cueva, Rosa Quiles, Sergio Ruíz, Ángela Ruíz‐Extremera & Javier Salmerón. (2011) Gender‐related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer. Molecular Carcinogenesis 51:8, pages 608-618.
Crossref
Crossref
Freerk T. Baumann, Elke Jäger & Wilhelm BlochElke Jäger. 2012. Sport und körperliche Aktivität in der Onkologie. Sport und körperliche Aktivität in der Onkologie
241
254
.
Jeffrey S Ross. (2011) Biomarker-based selection of therapy for colorectal cancer. Biomarkers in Medicine 5:3, pages 319-332.
Crossref
Crossref
Hanyin Cheng, Lina Zhang, David E. Cogdell, Hong Zheng, Aaron J. Schetter, Matti Nykter, Curtis C. Harris, Kexin Chen, Stanley R. Hamilton & Wei Zhang. (2011) Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis. PLoS ONE 6:3, pages e17745.
Crossref
Crossref
Giuseppe Petralia, Nicola Fazio, Luke Bonello, Gabriele D'Andrea, Davide Radice & Massimo Bellomi. (2011) Perfusion Computed Tomography in Patients With Hepatocellular Carcinoma Treated With Thalidomide. Journal of Computer Assisted Tomography 35:2, pages 195-201.
Crossref
Crossref
A Azzariti, G Bocci, L Porcelli, A Fioravanti, P Sini, G M Simone, A E Quatrale, P Chiarappa, A Mangia, S Sebastian, D Del Bufalo, M Del Tacca & A Paradiso. (2011) Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer. British Journal of Cancer 104:5, pages 769-780.
Crossref
Crossref
Dimitrios J. Stravopodis, Panagiotis K. Karkoulis, Eumorphia G. Konstantakou, Sophia Melachroinou, Angeliki Thanasopoulou, Gerasimos Aravantinos, Lukas H. Margaritis, Ema Anastasiadou & Gerassimos E. Voutsinas. (2010) Thymidylate synthase inhibition induces p53-dependent and p53-independent apoptotic responses in human urinary bladder cancer cells. Journal of Cancer Research and Clinical Oncology 137:2, pages 359-374.
Crossref
Crossref
Tamotsu Tsukahara, Shuwa Hanazawa, Tetsuyuki Kobayashi, Yoshiki Iwamoto & Kimiko Murakami-Murofushi. (2010) Cyclic phosphatidic acid decreases proliferation and survival of colon cancer cells by inhibiting peroxisome proliferator-activated receptor γ. Prostaglandins & Other Lipid Mediators 93:3-4, pages 126-133.
Crossref
Crossref
Jeffrey S. Ross, Jorge Torres-Mora, Nikhil Wagle, Timothy A. Jennings & David M. Jones. (2010) Biomarker-Based Prediction of Response to Therapy for Colorectal Cancer. American Journal of Clinical Pathology 134:3, pages 478-490.
Crossref
Crossref
Kazushi Suzuki, Toshio Kokuryo, Takeshi Senga, Yukihiro Yokoyama, Masato Nagino & Michinari Hamaguchi. (2010) Novel combination treatment for colorectal cancer using Nek2 siRNA and cisplatin. Cancer Science 101:5, pages 1163-1169.
Crossref
Crossref
Ziqiang Yuan, Joongho Shin, Andrew Wilson, Sanjay Goel, Yi-He Ling, Naseem Ahmed, Higinio Dopeso, Minaxi Jhawer, Shannon Nasser, Cristina Montagna, Kenneth Fordyce, Leonard H. Augenlicht, Lauri A. Aaltonen, Diego Arango, Thomas K. Weber & John M. Mariadason. (2009) An A13 Repeat within the 3′-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression. Cancer Research 69:19, pages 7811-7818.
Crossref
Crossref
Teneille Walker, Clint Mitchell, Margaret A. Park, Adly Yacoub, Martin Graf, Mohamed Rahmani, Peter J. Houghton, Christina Voelkel-Johnson, Steven Grant & Paul Dent. (2009) Sorafenib and Vorinostat Kill Colon Cancer Cells by CD95-Dependent and -Independent Mechanisms. Molecular Pharmacology 76:2, pages 342-355.
Crossref
Crossref